Michael Gelband’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-488,002
Closed -$5.29M 1963
2026
Q1
$5.29M Buy
+488,002
New +$4.18M 0.04% 421
2025
Q2
Sell
-239,983
Closed -$1.97M 1885
2025
Q1
$1.97M Sell
239,983
-271,748
-53% -$2.28M 0.02% 700
2024
Q4
$4.23M Buy
+511,731
New +$4.11M 0.03% 488
2023
Q4
Sell
-1,031,627
Closed -$14.3M 1941
2023
Q3
$14.3M Buy
1,031,627
+895,526
+658% +$13.1M 0.14% 159
2023
Q2
$1.63M Sell
136,101
-2,588
-2% -$29.2K 0.01% 897
2023
Q1
$1.62M Sell
138,689
-18,224
-12% -$266K 0.01% 966
2022
Q4
$2.64M Sell
156,913
-201,202
-56% -$3.32M 0.04% 537
2022
Q3
$4.18M Buy
358,115
+234,233
+189% +$3.35M 0.05% 467
2022
Q2
$1.95M Sell
123,882
-13,584
-10% -$228K 0.02% 790
2022
Q1
$2.13M Sell
137,466
-724,884
-84% -$9.15M 0.03% 751
2021
Q4
$7.29M Buy
862,350
+619,906
+256% +$5.34M 0.08% 303
2021
Q3
$2.18M Buy
+242,444
New +$1.96M 0.03% 692
2021
Q1
Sell
-265,679
Closed -$1.4M 2505
2020
Q4
$1.4M Buy
265,679
+227,856
+602% +$896K 0.01% 693
2020
Q3
$108K Buy
+37,823
New +$139K ﹤0.01% 1582
2019
Q4
Sell
-18,145
Closed -$155K 1817
2019
Q3
$155K Buy
+18,145
New +$178K 0.01% 1177

Other funds holding PTEN

Michael Gelband's PTEN Position: Q2 2026 in Review

Michael Gelband sold out of Patterson-UTI (PTEN) in Q2 2026, closing a stake of 488,002 shares — an estimated $5.29M sold.

Michael Gelband first reported a position in PTEN in Q3 2019 and held it in 15 quarters. The position peaked at $14.3M in Q3 2023. 435 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Michael Gelband reported no remaining Patterson-UTI position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 488,002 Patterson-UTI shares in Q2 2026, an estimated $5.29M.
  • Michael Gelband first reported a position in Patterson-UTI in Q3 2019 and held it in 15 quarters.
  • Michael Gelband's Patterson-UTI position peaked at $14.3M in Q3 2023.
  • 435 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.